CHU Amiens-Picardie
Amiens, 80054, France
NCT Number: NCT05153837
Human digestive system physiologically ensures the absorption of oral water and hydration of the human body. Water is quickly absorbed by the digestive tract with a peak between 15 and 20 minutes. It has demonstrated that oral water remains the best hydration solution that have an effect on plasma volume expansion and cardiovascular system during exercise. While the cardiovascular effect of fluid expansion by saline serum is well known (venous return, preload and cardiac output), effect of oral water varies in the literature depending on the physiological state of the patient and the clinical state. Thus, the investigators aim to investigate oral water effects on fluid responsiveness, regional blood flow and microcirculatory changes.
Looking for future studies?
Notify Me18 year–30 year
All sexes
Interventional
Not applicable
Amiens, 80054, France
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Administration of 500 mL of saline (NaCl 0.9%) administered by the venous route
500 ml oral water
Time frame: 30 minutes after fluid expansion
Centre Hospitalier Universitaire, Amiens
Other
Acronym: WATERNAL
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03924674
ADH Inappropriate, Brain Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT01941472
Cardiovascular Diseases, Fluid Challenge
Beijing, Beijing Municipality, China
View Trial DetailsNCT06772038
Cardiovascular Diseases, Fluid Challenge
Guangzhou, Guangdong, China
View Trial DetailsNCT07580144
Atrophy, Frailty
Konya, Turkey (Türkiye)
View Trial Details